Dr. Lal PathLabs Limited records growth of 17.7% in Q1 FY2016-17
New Delhi, India, July 29, 2016 – Dr. Lal PathLabs Limited (referred to as the “Company”; NSE: LALPATHLAB, BSE: 539524), a leading diagnostic and related healthcare service provider announces their financial results for the quarter ended June 30, 2016
Consolidated Performance Highlights: Q1FY2016-17 vs.
↧